Gavin Little-Gill

Gavin Little-Gill leads the Enfusion Product Go-To-Market strategy.  Gavin brings a wealth of knowledge from his 25+ years in the financial services software industry in strategy, product management, partner management and general management roles.

Gavin began his career in the mutual fund divisions of DWS and Natixis. He previously served as Head of Research for TowerGroup’s (now Gartner) Investment Management and Capital Markets practices, and held senior roles including Head of Asset Management Product Strategy at Linedata and Head of North America Partnerships at Broadridge. Before joining Clearwater, Gavin led the Capital Markets and Wealth Management practices at Datos.